'Supplementary figure 4' diaporamas de présentation

580K

Supplementary Figure 1. Segmental duplication in telomere fo Chr3s. 580K. 550K. 560K. 570K. ChrSy. Chromosome location. 40K. 1 0K. 2 0K. 30K. Chr3S. Supplementary Figure 2. Illustration of origination pattern and mechanisms of all new gene in O. sativa Chr3s. TAG. ATG. ATG. TAA.

252 views • 14 slides

Supplementary figure 1

220 views • 11 slides

Supplementary Figure 1

Supplementary Figure 1. Red: stable co-clustering Blue: no co-clustering. 2-cluster. 3-cluster. 5-cluster. 4-cluster. Supplementary Figure 2. Supplementary Figure 3. EGFR mutation. P=0.16. Supplementary Figure 4. Supplementary Figure 5. EGFR mutation. Supplementary Figure 6.

213 views • 10 slides

120

165 views • 4 slides

Supplementary Figure 1

Supplementary Figure 1. Venkatachalam et al. 2013. ab. a. ab. abc. c. 24 48 72 96 120. Hours after FB17 treatment. Supplementary Figure 2. Venkatachalam et al. 2013. At1g11610. At3g28360. At1g21240. At3g14460. At3g20190. UBQ1.

133 views • 4 slides

figure s1 The arrows point to the index patients. a., b. and c.

a. b. c. figure s1 The arrows point to the index patients. a., b. and c. are case one to three, respectively. g.w.= gestational week s.a. = spontaneos abortion i.a. = induced abortion. A. B. C.

40 views • 4 slides

DMSO

Supplementary Figure 4. A. FN. DMSO. DMSO. PP2. pFGFR1 (pY653/654). pFGFR1 (pY766). FGFR1. pAkt. Akt. ?- Actin. B. LacZ Src-Wt Src-419F Src-530F. pFGFR1 (pY653/654) pSrc Src Actin. (SRC mutants in absence of FN).

218 views • 1 slides

Supplementary Figure 4

A. - - + + - - + +. - - - - + + + +. - + - + - + - +. DCB. VPA. LC3-I. TRAIL. LC3-II. b -actin. B. -. CQ, 25 ? M. 8.5. 0.9. 1.4. 0.4. -. 14.1. 76.5. 4.8. 93.4. 7.1. 0.9. 2.5. 0.2.

56 views • 1 slides

Supplementary Figure 4

Supplementary Figure 4. A. B. Number of Colonies. Npm1+/+. Npm1+/-. Npm1+/-. Npm1+/+. I II III IV. CFU-GM. CFU-GEMM. p values 0.7 0.8 1.0 0.4.

72 views • 1 slides

Supplementary Figure 4

Supplementary Figure 4.

63 views • 1 slides

Gentile et al., Supplementary Figure 4

HGF 1h. HGF 6h. HGF 24h. 1. 0.5. 0. -0.5. -1. -1.5. -2. -2.5. -3. Abr. Bcr. Chn2. Sh3bp1. Arhgap5. Arhgap9. Arhgap1. Racgap1. Arhgap29. Arhgap12. Log2 Ratio. Gentile et al., Supplementary Figure 4

105 views • 1 slides

Supplementary Figure 4

Supplementary Figure 4.

60 views • 1 slides

Desjardins, et. al., Supplementary Figure 4

Desjardins, et. al., Supplementary Figure 4. *.

62 views • 1 slides

Sample 2

Supplementary Figure 4. b). a). 1 st PHA expansion. 2 nd PHA expansion. 3 rd PHA expansion. 4 th PHA expansion. 5 th PHA expansion. 6 th PHA expansion. 14 days. 14 days. 14 days. 14 days. 14 days. 14 days. Biopsy. Sample 1. Sample 2. Sample 3. Sample 4. Sample 5.

72 views • 1 slides

LDH release (24 hours)

Supplementary Figure 4. C. HSC/MFs. D. MSC. LDH release (24 hours). LDH release (24 hours). **. **. *. % LDH release. % LDH release. ?M. C 1 100 1000 100 500 1000. ?M. C 1 100 1000 100 500 1000. APO.

183 views • 1 slides

n=7

Supplementary Figure 4. n=7.

92 views • 1 slides

Supplementary Figure 4

Supplementary Figure 4.

74 views • 1 slides

? Spearman = 0.46

? Spearman = 0.46. ? Spearman = 0.24. ? Spearman = 0.24. ? Spearman = 0.32. ? Spearman = 0.55. ? Spearman = 0.33. ? Spearman = 0.17. ? Spearman = 0.12. Supplementary Figure 4.

120 views • 1 slides

Caspase-3

36. Caspase-3. Caspase-7. 36. 50. Actin. MCF-7 Jurkat. kDa. Supplementary Figure 4.

101 views • 1 slides